What does the Congenital Afibrinogenemia Gene Panel include at Metropolis Healthcare?
It includes targeted sequencing of genes involved in fibrinogen synthesis and regulation.
How does Metropolis Healthcare perform this genetic test?
Metropolis Healthcare uses advanced NGS technology with detailed bioinformatic analysis to detect clinically relevant variants.
Who should consider taking this test at Metropolis Healthcare?
Individuals with unexplained bleeding, very low fibrinogen levels, or a family history of bleeding disorders may benefit.
What type of sample is required for this panel at Metropolis Healthcare?
A blood sample collected in an EDTA tube is needed for sequencing.
How does this test help in clinical management?
It confirms the genetic cause, guides treatment options, and assists in long-term monitoring.
How long does Metropolis Healthcare take to deliver the report?
Reports are typically available within 2–4 weeks based on analysis complexity.
Can this panel detect carriers of afibrinogenemia?
Yes, it can identify carriers, which is helpful for family planning and genetic counseling.
Is genetic counseling recommended after this test at Metropolis Healthcare?
Yes, counseling helps interpret results and understand inheritance risks.